<DOC>
	<DOCNO>NCT01901107</DOCNO>
	<brief_summary>The purpose survey evaluate safety efficacy long-term use KiklinÂ® Capsules actual clinical setting .</brief_summary>
	<brief_title>Post-marketing Surveillance Kiklin Capsules Hemodialysis Patients</brief_title>
	<detailed_description>Bixalomer administer initial oral dosage 500 mg three time day meal . The dosage adjust base symptom serum phosphorus level .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Hyperphosphatemia</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Chronic renal failure patient hyperphosphataemia receive hemodialysis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hemodialysis</keyword>
	<keyword>CKD ( chronic kidney disease )</keyword>
	<keyword>ASP1585</keyword>
	<keyword>Hyperphosphatemia</keyword>
</DOC>